POLISCOPE
Back to feed
HR9790FEDERALin_committee

Modernizing Opioid Treatment Access Act 2.0 of 2026

July 20, 2026

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Where This Stands

Introduced
Committee
Floor Vote
Passed
Signed

Currently in_committee. The next step in the legislative lifecycle is Floor Vote.

Last action
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.Jul 20, 2026

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

The bill aims to change the regulatory framework for opioid treatment programs, which directly impacts the availability and delivery of addiction recovery services for patients nationwide.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Opioid use disorder patients

The bill proposes changes to the regulatory framework governing their access to treatment services.

Opioid treatment programs

These facilities are subject to the federal regulations and potential policy updates outlined in the bill.

What changed

Current stage: in_committee.

What's next

Floor Vote.

Summary

This bill proposes updates to federal regulations governing how patients access . It has been referred to the House Committees on Energy and Commerce and the Judiciary for review.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Why It Matters

The bill aims to change the regulatory framework for opioid treatment programs, which directly impacts the availability and delivery of addiction recovery services for patients nationwide.

Frequently Asked Questions

What is the current status of this bill?
The bill is currently in committee, meaning it is being reviewed by the House Committee on Energy and Commerce and the House Committee on the Judiciary.
What does this bill aim to do?
The bill seeks to modernize access to opioid treatment, though specific regulatory changes are determined during the committee review process.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Legislative Iteration

The '2.0' designation in the title indicates this is a follow-up or revised attempt at legislation regarding opioid treatment access.

Connected Entities

personGrijalva, RubenCo-sponsor of the bill in the House of RepresentativesMap →
personCraig, LisaCo-sponsor of the bill in the House of RepresentativesMap →
personPappas, SethCo-sponsor of the bill in the House of RepresentativesMap →
personSalinas, MarianaCo-sponsor of the bill in the House of RepresentativesMap →
personKuster, AnnieCo-sponsor of the bill in the House of RepresentativesMap →
organizationCommittee on Energy and CommerceCongressional committee currently reviewing the bill.Map →
personNeguse, JasonCo-sponsor of the bill in the House of RepresentativesMap →
personNickel, MikeCo-sponsor of the bill in the House of RepresentativesMap →
organizationAttorney GeneralResponsible for implementing and enforcing the Controlled Substances ActMap →
personHorsford, TedCo-sponsor of the bill in the House of RepresentativesMap →
personStansbury, StephanieLead sponsor of the bill in the House of RepresentativesMap →
organizationCommittee on the JudiciaryCongressional committee currently reviewing the bill.Map →
personPettersen, KendraCo-sponsor of the bill in the House of RepresentativesMap →

Analysis Score

0–100
  • Significance65
    How much this matters to a regular citizen
  • Controversy40
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz20
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record